Treffer: McCollough and Watercolor Effects: Visual Illusions that Fade in Early Alzheimer's Disease.
Original Publication: Warsaw, Poland : Medical Science International
J Vis. 2008 Sep 19;8(12):4.1-12. (PMID: 18831617)
Alzheimers Dement. 2011 May;7(3):270-9. (PMID: 21514249)
Behav Sci (Basel). 2015 Jul 31;5(3):353-71. (PMID: 26264031)
J Alzheimers Dis. 2019;72(4):1233-1240. (PMID: 31683482)
Vision Res. 2002 May;42(10):1259-86. (PMID: 12044758)
Vision Res. 2018 Mar;144:9-19. (PMID: 29355565)
Percept Psychophys. 1991 May;49(5):448-55. (PMID: 2057310)
Nat Rev Neurosci. 2006 Mar;7(3):220-31. (PMID: 16495943)
Vision Res. 2001 Sep;41(20):2669-76. (PMID: 11520512)
Brain. 2019 Jun 1;142(6):1723-1735. (PMID: 31009046)
J Neurosci. 2008 Aug 6;28(32):8096-106. (PMID: 18685034)
J Geriatr Psychiatry Neurol. 2018 Mar;31(2):97-102. (PMID: 29658429)
Alzheimers Dement. 2024 May;20(5):3708-3821. (PMID: 38689398)
Nat Neurosci. 2006 Jul;9(7):873-4. (PMID: 16767088)
Front Hum Neurosci. 2022 Dec 08;16:960542. (PMID: 36569477)
Percept Psychophys. 2000 Feb;62(2):350-62. (PMID: 10723214)
Conscious Cogn. 1998 Sep;7(3):494-519. (PMID: 9787058)
Science. 2001 Aug 31;293(5535):1677-80. (PMID: 11533495)
Alzheimers Dement. 2014 Mar;10(2):251-61. (PMID: 24011928)
Science. 1965 Sep 3;149(3688):1115-6. (PMID: 17737844)
Invest Ophthalmol Vis Sci. 2022 May 2;63(5):20. (PMID: 35579902)
Nature. 1962 Dec 22;196:1143-5. (PMID: 14025557)
J Vis. 2011 Mar 31;11(3):. (PMID: 21454856)
Perception. 2000;29(4):461-80. (PMID: 10953765)
Brain. 2020 Jul 1;143(7):2281-2294. (PMID: 32572464)
Alzheimers Dement. 2011 May;7(3):263-9. (PMID: 21514250)
Sci Rep. 2019 Jun 18;9(1):8698. (PMID: 31213626)
Curr Biol. 2009 Apr 28;19(8):R323-4. (PMID: 19409278)
Weitere Informationen
BACKGROUND Visual illusions provide insight into visual perception processes. We examined the McCollough effects (ME) and watercolor effects (WE) in patients with early Alzheimer disease (AD) and cognitively healthy older adults, and evaluated the influence of acetylcholinesterase inhibitors in the AD mild dementia (MD) stage. MATERIAL AND METHODS We included 28, 27, and 26 patients with MD, amnestic mild cognitive impairment (MCI), and normal cognition (control group), respectively. Participants completed the CDR, MMSE, ADAS-Cog 13, Ishihara test, and ME and WE evaluations. ME was evaluated by identifying chromatic changes in vertical, horizontal black, and white line patterns. WE was evaluated by identifying white or colored sections. RESULTS Regarding ME, white vertical lines appeared red, with no significant differences between groups (H=0.834, P=0.659). Differences were observed in perception of white horizontal lines as green (H=10.27, P=0.006). All in the control group, 25 of 27 in MCI group, and 22 of 28 in MD group reported seeing WE (Fisher exact 6.66, P=0.024). In binary logistic regression, cognitive tests and Ishihara results predicted perception of WE. Regarding MD, no significant differences were reported between patients taking or not taking acetylcholinesterase inhibitors (chi-square 0.749, P=0.38; P=0.19, P=1.00, respectively). CONCLUSIONS Perceptions of ME and WE differed significantly between cognitively normal participants and those with early AD, offering insights into the functional alterations of the visual system and ongoing neurodegeneration. The ME after-effect of red horizontal lines might represent very early AD changes, which could aid in a better understanding of AD visual perception.